Episode Details

Pharmaceutical giants are shelling out billions of dollars lately to buy promising new drugs. Is this a sign of good financial health, or a problem with pipelines? We’ll discuss.

Plus, there’s more and more data coming out on Shein as it prepares for a U.S. IPO. We’ll break down it’s revenue numbers, and where it ranks compared to American retailers.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.